Quetiapine (drug)

DRUG3 trials

Sponsors

Medical University of Vienna, Université de Montréal, First Affiliated Hospital of Zhejiang University

Conditions

Bipolar Disorder IIOcular PhysiologyRegional Blood FlowSchizophreniaSubstance Use Disorders

Phase 2

Efficacy and Mechanism of IPSRT for Bipolar II Disorder

Not yet recruitingNCT07654348

First Affiliated Hospital of Zhejiang UniversityBipolar Disorder II

Start: 2026-07-01End: 2029-07-01Target: 216Updated: 2026-06-17

Phase 4

The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients

CompletedNCT00295412

Université de MontréalSchizophrenia, Substance Use Disorders

Updated: 2006-02-23

Unknown Phase

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

CompletedNCT00280501

Medical University of ViennaOcular Physiology, Regional Blood Flow

Start: 2005-08-31End: 2006-08-31Updated: 2008-07-09